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http://dx.doi.org/10.1016/j.jfma.201This report presents a case of a 12-year-old girl with maxillary deficiency, mandibular progna-
thism, and facial asymmetry, undergoing growth hormone (GH) therapy due to idiopathic short
stature. Children of short stature with or without GH deficiency have a deviating craniofacial
morphology with overall smaller dimensions; facial retrognathism, especially mandibular ret-
rognathism; and increased facial convexity. However, a complete opposite craniofacial pattern
was presented in our case of a skeletal Class III girl with idiopathic short stature. The ortho-
dontic treatment goal was to inhibit or change the direction of mandibular growth and stimu-
late the maxillary growth of the girl during a course of GH therapy. Maxillary protraction and
mandibular retraction were achieved using occipitomental anchorage (OMA) orthopedic appli-
ance in the first stage of treatment. In the second stage, the patient was treated with a fixed
orthodontic appliance using a modified multiple-loop edgewise archwire technique of asym-
metric mechanics and an active retainer of vertical chin-cup. The treatment led to an accept-
able facial profile and obvious facial asymmetry improvement. Class I dental occlusion and
coincident dental midline were also achieved. A 3½-year follow-up of the girl at age 18 showed
a stable result of the orthodontic and dentofacial orthopedic treatment. Our case shows thatof Dentistry, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, Kaohsiung 80756, Taiwan.
tw (H.-P. Chang).
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802 C.-Y. Pan et al.Figure 1 Height growththe OMA orthopedic appliance of maxillary protraction combined with mandibular retraction is
effective for correcting skeletal Class III malocclusion with midface deficiency and mandibular
prognathism in growing children with idiopathic short stature undergoing GH therapy.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction treatment. The main purpose of this case report was toGrowth hormone (GH) is a polypeptide hormone, secreted
by the anterior part of the hypophysis, and plays a major
role in craniofacial and skeletal growth.1 Since biosynthetic
human GH obtained by genetic recombination became
widely available in 1985,2 clinicians have been working to
extend the use of recombinant human GH for short-stature
children with classic GH deficiency to as many categories of
short-stature children as possible. Therefore, its applica-
tion in children was widened to various diseases such as
Turner or Noonan syndromes, chronic renal failure, children
born small for their gestation age, PradereWilli syndrome,
and idiopathic short stature.1,2 Cephalometric studies of
children with GH deficiency have shown the following
craniofacial characteristics: small anterior and posterior
cranial base dimensions, steep mandibular plane angle, and
small mandibular sizes including the total mandibular
length and smaller ramal height.3,4 Orthodontists should
understand the characteristics of craniofacial morphology
in idiopathic short-stature children and the effects of GH
therapy on these patients prior to beginning orthodonticcurve5 for patient.present an orthodontic case of skeletal Class III girl,
undergoing GH therapy due to idiopathic short stature.
Case report
A 12-year-old girl came to our hospital with a protruded
mandible and everted lower lip as the chief complaint. She
had been diagnosed as having idiopathic short stature at
age 10. The patient had a normal birth height and weight
for her gestational age. However, she showed a slow post-
natal growth rate and short stature. The hand-wrist radio-
graph showed that her skeletal age was delayed by 1 year
2 months compared with the chronologic age of 10. Clinical
or laboratory evidence revealed no systemic disease of
dysmorphic features. She received GH treatment at
a medical center in Kaohsiung for 4 years, starting at age
10. The GH treatment was effective, and she had prom-
inent somatic growth until her menstruation commenced at
age 13. The patient was initially 126 mm below the fifth
percentile of body height for Taiwanese girls of age 105;
during the GH therapy, she moved up 135.5 mm into the
15th percentile at age 11; and 146 and 151.2 mm at age 12
and 13, respectively; and 154 mm into the 20th percentile
when GH therapy ended at age 14, which was maintained
through age 15e18 (Fig. 1). The patient’s weight, initially
22.2 kg, increased to 26.5 kg below the fifth percentile of
body height for Taiwanese girls of age 10 and 11, respec-
tively, and increased to 32, 35.6, and 37.2 kg around the
fifth percentile, and then to 38.5, 39.5, and 41 kg which
were below the fifth percentile of age 14, 15, and 18,
respectively (Fig. 2).5
Orthodontic examination showed that the girl had
anterior crossbite and skeletal Class III malocclusion (T1)
(Fig. 3 and Table 1). She had a concave facial profile with
maxillary deficiency and mandibular prognathism, and
facial asymmetry with the mandible deviated to the rightFigure 2 Weight growth curve5 for patient.
Figure 3 Pretreatment extraoral and intraoral photographs.
Mandibular prognathic girl of short stature 803side. We used the occipitomental anchorage (OMA) ortho-
pedic appliance for maxillary protraction and mandibular
retraction6,7 in the first stage of treatment (T2), which
lasted for 6 months. In the second stage (T3), the patientTable 1 Cephalometric measurements.
T1 T2 T3 T4
SNA () 82 82 83 83
SNB () 85 83 84 84
ANB () e3 e1 e1 e1
A-Nv (mm) 0 0.5 3.5 3.0
B-Nv (mm) 5.5 3.0 6.0 6.0
Pg-Nv (mm) 5.5 3.1 7.5 7.5
S-N (mm) 64 65.5 65.5 65.5
N-Me (mm) 113.5 120 120 120.5
N-A (mm) 58 58.5 58.5 59
A-Me (mm) 55.5 61.5 61.5 62
S-Go (mm) 65.5 66.5 68 68
PFH/AFH (%) 57.7 55.4 56.7 56.4
Ptm-A (NF) (mm) 44 45.5 48 48.5
Ar-Go (mm) 41.5 41.5 42.5 42.5
Ar-A (mm) 78.5 79.5 80 81
Ar-Gn (mm) 109 111.5 113 114
Mx/Mn (%) 72 71.3 70.8 71.1
Go-Gn (mm) 75 78 79.5 79.5
SN-MP () 37 41 40 39.5
U1-SN () 115 118 118 117.5
IMPA () 80.5 84.5 77 77
T1 Z prior to treatment; T2 Z after orthopedic treatment;
T3 Z after orthodontic treatment; T4 Z 3½-year follow-up.was treated with a fixed orthodontic appliance using
a modified multiple-loop edgewise archwire (MEAW) tech-
nique and an active retainer of vertical chin-cup for 2 years
and 6 months. The modified MEAW technique used asym-
metric mechanics for correcting facial asymmetry and
dental midline deviation,8,9 which involved extrusive
mechanics on the right side and intrusive mechanics on the
left side. The treatment achieved an acceptable facial and
more convex profile, and obviously improved facial asym-
metry (Fig. 4). Class I dental occlusion with coincident
dental midline was also achieved. A follow-up of 3 years
and 6 months of the girl at age 18 (T4) showed that the
result of the orthodontic and dentofacial orthopedic
treatment was stable (Fig. 5).Discussion
Craniofacial morphology of children of idiopathic short
stature is similar to those with GH deficiency, although less
pronounced.10 Children of short stature with or without GH
deficiency have a deviating craniofacial morphology with
overall smaller dimensions; facial retrognathism, especially
mandibular retrognathism; increased facial convexity; and
increased posterior rotation of the mandible.11 Craniofacial
changes induced by GH treatment yield a more prognathic
growth pattern, a more anterior position of the jaws in
relation to the cranial base, and increased anterior rotation
of the mandible. Mandibular body length and anterior face
height of the GH-treated children with mandibular retro-
gnathism are greater than those in the normal control
group.12
Figure 4 Post-treatment extraoral and intraoral photographs.
Figure 5 Three-and-a-half-year follow-up extraoral and intraoral photographs.
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Figure 6 Superimposed cephalometric tracing before and
after treatments. T1 Z prior to treatment; T2 Z after occi-
pitomental anchorage orthopedic therapy; T3 Z after ortho-
dontic treatment with an active retainer of vertical chin-cup.
Mandibular prognathic girl of short stature 805Studies observed a relatively high prevalence of Class III
malocclusion, from 15% to 23%, in Asian populations.13 In
contrast, most studies have reported an incidence of below
5% for this class of malocclusion in Caucasian populations.
Class III malocclusion is thus a common clinical problem in
orthodontic patients of Asian or Mongoloid descent. Class III
malocclusion is generally a skeletal type of occlusal varia-
tion, and treatment of a skeletal Class III condition in
growing children remains one of the most challenging
problems confronting the practicing orthodontist.
Craniofacial morphology with a polygenic, quantitative
trait has a significant genetic component, but it is also
influenced by environmental factors and functional adap-
tations.14,15 Researchers have recently reported that
single-nucleotide polymorphisms (SNPs) in the growth
hormone receptor (GHR) gene are associated with
mandibular ramus height in Japanese, Korean, and Han
Chinese population.15e18 The SNPs of the GHR gene are
likely to be different in different ethnic groups. This might
partly explain the differing craniofacial morphology among
different ethnicities.
Although GH stimulates overall growth of the craniofa-
cial complex, it is most effective in those regions where
cartilage-mediated growth occurs, such as the condylar
cartilage of the mandible, and in regions adapting for this
cartilage growth.19,20 Growth increment is most marked in
posterior face height, which reflects mandibular growth.
Accelerated mandibular growth caused by GH therapy
might affect orthodontic treatment. Correcting the ante-
rior crossbite and prognathic mandible in patients of skel-
etal Class III cases during GH therapy is difficult.
Considering that GH has a greater effect on the mandible
than on the maxilla and mandibular growth is unpredict-
able, we should plan a more active treatment for the
patient.
After correction of anterior crossbite, the maxillary
length (Ptm-A/NF), projected on the nasal floor or palatal
plane, increased by 1.5 mm (from 44 to 45.5 mm) during
OMA orthopedic therapy with maxillary protraction and
mandibular retraction (T2), and then this length increased
by 2.5 mm (from 45.5 to 48 mm) during orthodontic treat-
ment with an active retainer of vertical chin-cup (T3). The
effective mandibular length (Ar-Gn) increased by 4 mm
(from 109 to 113 mm) during the same period (T2 and T3)
(Table 1 and Fig. 6), while the normal effective mandibular
length should increase by 6 mm (from 105 to 111 mm)
during the same period.21
The effective mandibular length (Ar-Gn) increased by
4 mm (from 109 to 113 mm) during OMA orthopedic therapy
(T2) and orthodontic treatment with an active retainer of
vertical chin-cup (T3) at the same time during GH therapy,
and then increased by 1 mm up to 114 mm during follow-up
at 18 years of age (T4) (Table 1 and Fig. 6), while the
normal effective mandibular length for Taiwanese girls
should increase by 6 mm (from 105 to 111 mm) and then by
2 mm up to 113 mm at 18 years of age.21 Therefore, the
effective mandibular length diminished by 2 mmmainly due
to the effect of mandibular retraction of OMA orthopedic
therapy and an active retainer of vertical chin-cup.
The OMA orthopedic appliance of maxillary protraction
combined with mandibular retraction is effective for cor-
recting skeletal Class III malocclusion with midfacedeficiency and mandibular prognathism in growing chil-
dren.6,7 The OMA appliance corrected the mesial jaw
(skeletal Class III) relationship and anterior crossbite
(negative incisal overjet) of the girl undergoing GH therapy.
After orthopedic treatment, a vertical chin-cup was used as
an active retainer in the second stage of orthodontic
treatment. At the end of the treatment, the patient of 15
years was beyond the pubertal growth spurt, with only
minor growth remaining.
GH therapy enhanced growth in both craniofacial
complex and stature. The effective mandibular length and
anterior face height values approached the norms at the
end of the treatment. The increase did not result in a Class
III skeletal or dental relationship, nor was the increase
worse for facial appearance.
The patient’s father and mother’s body heights are
165 cm and 154 cm, respectively, and the achieved adult
height of the patient is 154 cm. However, the patient’s
elder brother’s height is 180 cm. Our case showed that GH
therapy is effective for improving the achieved adult height
of the patient with idiopathic short stature.Acknowledgments
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